Lipase Reagent Market Share

North American Market Forecast

North America industry is set to hold largest revenue share of 36% by 2037, on the back of increasing concern among people about complications related to the gastrointestinal tract. Among 440 million non-cancer medical conditions, over 22 million acute digestive conditions with 11 million gastroenteritis and 6 million indigestion cases are reported. Besides, the North American region is having good infrastructure and more hospitals propelling the growth of the global lipase reagent market during the forecast period. According to the American Hospital Association, the total number of all hospitals in the North American region is 6,000 with staffed beds of 920,000 in 2022. Also, the regional government policies towards public health care programs attribute to the growth of the market.

APAC Market Statistics

Moreover, the Asia Pacific lipase reagent market is also growing at a fast rate, owing to the rising demand for lipase reagents in the pharma, food and beverage, and biotech sectors. The need for lipase reagents for use in developing drugs, biomarker identification, and bioprocessing applications is rising as a result of the rapidly developing biotechnology and pharmaceutical sectors. The requirement for lipase reagents in the detection and treatment of lifestyle-related disorders like diabetes and obesity is rising as their prevalence rises. The need for lipase reagents for use in food evaluation and quality control is also rising as a result of the region's expanding food and beverage industries, notably in nations like China and India.